Seroprevalence of hepatitis B and delta viruses among HIV-infected population attending anti-retroviral clinic in selected health facilities in Abuja, NigeriaArticle Published on 2017-01-012023-06-16 Journal: Journal of immunoassay & immunochemistry [Category] B형 간염, [키워드] Abuja antiretroviral ELISA HIV/HBV/HDV Nigeria seroprevalence. [DOI] 10.1080/15321819.2017.1372474 PMC 바로가기
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trialHIV-1에 감염된 건강한 성인에서 후보 결핵 백신 MVA85A의 안전성, 면역원성 및 효능: 무작위, 위약 대조, 2상 시험Articles Published on 2015-03-012022-09-06 Journal: The Lancet. Respiratory Medicine [Category] Communicable Disease, [키워드] 1:1 95% CI absence active tuberculosis adverse event Antigen antigen 85A antigen 85A-specific T-cell response antiretroviral Antiretroviral therapy assigned assist baseline baseline CD4 block blocks booster Cape CD4 count CD4 counts Cell clinical defined detect detectable Developing disease double-blind effective Efficacy eligible Eligible participants enrolled enrolment European Evidence evidence of expressing finding first vaccination foundation funding gold greater Group allocation had no healthy HIV-1 HIV-1 infection immunogenic immunogenicity include increased risk Infection injection intradermal injections investigators isoniazid isoniazid prophylaxis Laboratory latent tuberculosis latent tuberculosis infection M tuberculosis Measures Melinda Gate Melinda Gates modified vaccinia virus MVA85A Mycobacterium tuberculosis nine no evidence of Nurses occurred outcome participant partnership peaked per-protocol analysis per-protocol population Phase 2 phase 2 trial Placebo placebo group placebo-controlled positive Potential Prophylaxis protocol QuantiFERON QuantiFERON-TB Gold In-Tube randomisation randomised Randomly receive receiving Registered reported Safe Safety safety analysis second vaccination secondary Secondary outcomes sequence Serious Adverse Event Serious Adverse Events significant increase South Africa stratified subset T-cell Response the placebo group therapy town Treatment Trial Tuberculosis tuberculosis disease tuberculosis vaccine undetectable vaccination Vaccine vaccine efficacy vaccine-induced immune response Viral Viral load Wellcome Trust were assessed [DOI] 10.1016/S2213-2600(15)00037-5 PMC 바로가기 [Article Type] Articles
Effects of Spirulina platensis supplementation on lipid profile in HIV–infected antiretroviral naïve patients in Yaounde – Cameroon: a randomized trial study야운데 - 카메룬에서 HIV에 감염된 항레트로바이러스 경험이 없는 환자의 지질 프로필에 대한 스피루리나 플라텐시스 보충제의 효과: 무작위 시험 연구Research Published on 2014-12-132022-09-06 Journal: Lipids in Health and Disease [Category] Communicable Disease, [키워드] abnormality age alteration antiretroviral Atherosclerosis average average age balanced diet baseline BMI body fat body mass body mass index cardiovascular cardiovascular diseases cardiovascular dysfunction cardiovascular risk factors CD4 cholesterol conducted contributing to CVD defined determine disease dyslipidemia Effect Factor fat distribution female Food Intake HDL-C HDL-cholesterol HIV HIV+ antiretroviral naïve include infections Inflammation insulin insulin resistance LDL-C LDL-cholesterol lipid profile Local local food majority metabolic syndrome multicentre naïve participant Patient patients public health Quantitative Randomized randomized trial recruited reported Result screened significant decrease significant increase significantly single-blind Spirulina platensis syndrome the patient Total cholesterol Triglyceride triglycerides variable weight were assessed with HIV [DOI] 10.1186/1476-511X-13-191 PMC 바로가기 [Article Type] Research
Expanding the frontiers of existing antiviral drugs: Possible effects of HIV-1 protease inhibitors against SARS and avian influenzaArticle Published on 2005-05-122022-11-01 Journal: Journal of Clinical Virology [Category] Coronavirus, Fulltext, 조류인플루엔자, [키워드] acute respiratory syndrome antiretroviral Antiviral antiviral drug Clinical studies computational simulation coronavirus disease docking Effect Evidence HIV-1 protease inhibitor humans imperative in silico in vivo Influenza Influenza virus influenza viruses inhibition assay PI Possible potential benefit potential therapeutic agent protease provided public health RNA-dependent RNA polymerase Safe SARS SARS Coronavirus SARS-CoV subunit suggested therapy these compound Type-A influenza viral disease [DOI] 10.1016/j.jcv.2005.03.005 PMC 바로가기 [Article Type] Article